ArticleFrontiers in public health2022
Analysis on alteration of road traffic casualties in western China from multi-department data in recent decade.
Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Vulnerability of the border area: analysis of the Traffic Accident Analysis System in Korea.Journal of trauma and injury · 2025Article
- Trends in transport injuries burden and risk factors among children under 14 years old in China: 1990-2019.BMC public health · 2024Article
- The impact of high-altitude and cold environment on brain and heart damage in rats with hemorrhagic shock.Brain circulationArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Road traffic safety has considerably improved in China. However, the changes may differ in the economically backward and altitude higher western region. This study aims to investigate changes in the occurrence and severity of traffic casualties in western China and illuminate several key causal factors. Materials and methods: Traffic accident data from the Annual Traffic Accident Statistics Report combined with population and vehicle data from the China Statistics Bureau between 2009 and 2019, were retrospectively analyzed. Traffic accident numbers, fatalities, human injury (HI), case fatality rates (CFR), mortality per 100,000 population (MRP), and mortality per 10,000 vehicles (MRV) were compared between the western and eastern regions. The HI, CFR, MRV, and MRP between the four groups based on the altitude of cities, below 500 meters, 500 to 1,500 meters, 1,500 to 3,000 meters, and over 3,000 meters, were compared using one-way analysis of variance. One hundred and seventy-eight cases of extremely serious traffic accidents were further analyzed in terms of accident occurrence time, vehicle type, road grade, road shape, accident pattern, and accident reason. The differences of accident characteristics between the eastern and western regions were compared using the chi-square test. Results: The number of traffic accidents and fatalities decreased in low-altitude areas in western China. However, there was a significant increasing trend in the high altitude area. The HI, CFR, MRV, and MRP were higher in the western region than that in the eastern and national. Those accident indicators tended to increase with increasing altitude. And there were statistically significant differences ( Conclusion: Traffic accidents are increasing in high-altitude areas of western China, and they lead to more severe casualties. The characteristics of serious traffic accidents in this part of the country differ from those of the eastern regions. Improving road safety facilities, restrictions of speed, and improving medical treatment at accident scenes may be effective measures to reduce traffic accidents related injuries in the western region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.